FI922341A0 - Piperidin- och pyrrolidinderivat. - Google Patents
Piperidin- och pyrrolidinderivat.Info
- Publication number
- FI922341A0 FI922341A0 FI922341A FI922341A FI922341A0 FI 922341 A0 FI922341 A0 FI 922341A0 FI 922341 A FI922341 A FI 922341A FI 922341 A FI922341 A FI 922341A FI 922341 A0 FI922341 A0 FI 922341A0
- Authority
- FI
- Finland
- Prior art keywords
- alkyl
- pct
- formula
- group
- independently
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB909000301A GB9000301D0 (en) | 1990-01-06 | 1990-01-06 | Piperidine & pyrrolidine derivatives |
| PCT/EP1990/002039 WO1991010650A1 (en) | 1990-01-06 | 1990-11-28 | Piperidine and pyrrolidine derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI922341A FI922341A (fi) | 1992-05-22 |
| FI922341A0 true FI922341A0 (fi) | 1992-05-22 |
Family
ID=10668922
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI922341A FI922341A0 (fi) | 1990-01-06 | 1992-05-22 | Piperidin- och pyrrolidinderivat. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5344835A (fi) |
| EP (1) | EP0510003B1 (fi) |
| JP (1) | JPH0692365B2 (fi) |
| AT (1) | ATE128463T1 (fi) |
| CA (1) | CA2067758C (fi) |
| DE (1) | DE69022744T2 (fi) |
| DK (1) | DK0510003T3 (fi) |
| ES (1) | ES2078356T3 (fi) |
| FI (1) | FI922341A0 (fi) |
| GB (1) | GB9000301D0 (fi) |
| GR (1) | GR3017944T3 (fi) |
| IE (1) | IE69312B1 (fi) |
| PT (1) | PT96421B (fi) |
| WO (1) | WO1991010650A1 (fi) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5932594A (en) * | 1988-11-01 | 1999-08-03 | Pfizer, Inc. | Muscarinic receptor antagonists |
| GB9020051D0 (en) * | 1990-09-13 | 1990-10-24 | Pfizer Ltd | Muscarinic receptor antagonists |
| US5859295A (en) * | 1994-12-05 | 1999-01-12 | University Of Kentucky Research Foundation | Canavanine analogs and their use as chemotherapeutic agents |
| US5889006A (en) * | 1995-02-23 | 1999-03-30 | Schering Corporation | Muscarinic antagonists |
| IL117149A0 (en) * | 1995-02-23 | 1996-06-18 | Schering Corp | Muscarinic antagonists |
| CN1290251A (zh) * | 1998-02-04 | 2001-04-04 | 万有制药株式会社 | N－酰基环胺衍生物 |
| US6693202B1 (en) * | 1999-02-16 | 2004-02-17 | Theravance, Inc. | Muscarinic receptor antagonists |
| EP1165508B1 (en) * | 1999-04-07 | 2004-06-23 | The University of Virginia Patent Foundation | Anticancer calcium channel blockers |
| US8211916B2 (en) * | 2000-06-20 | 2012-07-03 | Wayne State University | N- and O-substituted 4-[2-(diphenylmethoxy)-ethyl]-1-[(phenyl)methyl]piperidine analogs and methods of treating CNS disorders therewith |
| AU2001275537A1 (en) * | 2000-06-20 | 2002-01-02 | Wayne State University | N-and o-substituted 4-(2-(diphenylmethoxy)-ethyl)-1-((phenyl)methyl)piperidine analogs and methods of treating cns disorders therewith |
| TW200800953A (en) * | 2002-10-30 | 2008-01-01 | Theravance Inc | Intermediates for preparing substituted 4-amino-1-(pyridylmethyl) piperidine |
| US8017791B2 (en) * | 2003-03-28 | 2011-09-13 | Wayne State University | Tri-substituted 2-benzhydryl-5-benzylamino-tetrahydro-pyran-4-ol and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-ol analogues, and novel, 3,6-disubstituted pyran derivatives |
| TW200510298A (en) * | 2003-06-13 | 2005-03-16 | Theravance Inc | Substituted pyrrolidine and related compounds |
| JP2007524641A (ja) * | 2003-07-11 | 2007-08-30 | セラヴァンス， インコーポレーテッド | 置換４−アミノ−１−ベンジルピペリジン化合物 |
| EP1725525A1 (en) * | 2004-03-11 | 2006-11-29 | Theravance, Inc. | Diphenylmethyl compounds useful as muscarinic receptor antagonists |
| WO2005087763A1 (en) * | 2004-03-11 | 2005-09-22 | Theravance, Inc. | Diphenylmethyl compounds useful as muscarinic receptor antagonists |
| EP1734948B1 (en) | 2004-04-16 | 2014-06-11 | Wayne State University | Tri-substitued 2-benzhydryl-5-benzylamino-tetrahydro-pyran-4-ol and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-ol analogues, and novel 3,6-disubstituted pyran derivatives |
| EP1768662A2 (en) | 2004-06-24 | 2007-04-04 | Novartis Vaccines and Diagnostics, Inc. | Small molecule immunopotentiators and assays for their detection |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE934890C (de) * | 1951-10-07 | 1955-11-10 | Chem Fab Promonta Ges Mit Besc | Verfahren zur Herstellung von basischen Benzhydrylaethern |
| GB780027A (en) * | 1955-01-20 | 1957-07-31 | Schering Corp | 3-piperidyl ethers and thioethers |
| US2974146A (en) * | 1956-02-24 | 1961-03-07 | Lakeside Lab Inc | 3-piperidyl benzhydryl ethers |
| EP0228893A3 (en) * | 1985-12-20 | 1990-01-03 | A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) | Arylalkyl-heterocyclic amines, n-substituted by aryloxyalkyl group in allergy treatment |
| US4810713A (en) * | 1985-12-20 | 1989-03-07 | A. H. Robins Company, Incorporated | Arylalkyl-heterocyclic amines, n-substituted by aryloxyalkyl groups used in a method for allergy treatment |
| GB8816365D0 (en) * | 1988-07-08 | 1988-08-10 | Pfizer Ltd | Therapeutic agents |
| ATE169616T1 (de) * | 1988-11-21 | 1998-08-15 | Zeneca Ltd | Zwischenverbindungen zur herstellung von fungiziden |
-
1990
- 1990-01-06 GB GB909000301A patent/GB9000301D0/en active Pending
- 1990-11-28 ES ES90917305T patent/ES2078356T3/es not_active Expired - Lifetime
- 1990-11-28 DE DE69022744T patent/DE69022744T2/de not_active Expired - Fee Related
- 1990-11-28 DK DK90917305.6T patent/DK0510003T3/da active
- 1990-11-28 US US07/890,595 patent/US5344835A/en not_active Expired - Fee Related
- 1990-11-28 EP EP90917305A patent/EP0510003B1/en not_active Expired - Lifetime
- 1990-11-28 WO PCT/EP1990/002039 patent/WO1991010650A1/en active IP Right Grant
- 1990-11-28 CA CA002067758A patent/CA2067758C/en not_active Expired - Fee Related
- 1990-11-28 JP JP3500113A patent/JPH0692365B2/ja not_active Expired - Fee Related
- 1990-11-28 AT AT90917305T patent/ATE128463T1/de not_active IP Right Cessation
-
1991
- 1991-01-04 PT PT96421A patent/PT96421B/pt not_active IP Right Cessation
- 1991-01-04 IE IE2091A patent/IE69312B1/en not_active IP Right Cessation
-
1992
- 1992-05-22 FI FI922341A patent/FI922341A0/fi not_active Application Discontinuation
-
1995
- 1995-11-01 GR GR950403053T patent/GR3017944T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI922341A (fi) | 1992-05-22 |
| DK0510003T3 (da) | 1996-01-29 |
| JPH05501560A (ja) | 1993-03-25 |
| WO1991010650A1 (en) | 1991-07-25 |
| PT96421B (pt) | 1997-05-28 |
| US5344835A (en) | 1994-09-06 |
| ES2078356T3 (es) | 1995-12-16 |
| EP0510003B1 (en) | 1995-09-27 |
| EP0510003A1 (en) | 1992-10-28 |
| IE910020A1 (en) | 1991-07-17 |
| CA2067758A1 (en) | 1991-07-07 |
| GR3017944T3 (en) | 1996-02-29 |
| DE69022744T2 (de) | 1996-03-07 |
| PT96421A (pt) | 1991-10-15 |
| IE69312B1 (en) | 1996-09-04 |
| JPH0692365B2 (ja) | 1994-11-16 |
| GB9000301D0 (en) | 1990-03-07 |
| CA2067758C (en) | 1994-12-13 |
| DE69022744D1 (de) | 1995-11-02 |
| ATE128463T1 (de) | 1995-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI922341A0 (fi) | Piperidin- och pyrrolidinderivat. | |
| DE69014901D1 (de) | Muscarin-rezeptor-antagonisten. | |
| DE69614270T2 (de) | 5-azabicyclo(3.1.0.)hexylalkyl-2-piperidone und - glutarimide als neurokinin receptor antagonisten. | |
| CA2328780A1 (en) | Dihydropyrimidines | |
| NZ511739A (en) | New esters derived from substituted phenyl-cyclohexyl compounds | |
| DE68900117D1 (de) | Muscarin-rezeptor-antagonisten. | |
| EP0335979A4 (en) | Thienopyrimidine derivatives | |
| DE69510510D1 (de) | N-benzoylmethylsubstituierte paroxetinderivate | |
| ATE162191T1 (de) | Azanoradamantane | |
| DE69526097D1 (de) | Bicyclische carboxamide als 5-ht1a rezeptoren liganden | |
| KR960007560A (ko) | 신규한 아민 유도체, 그의 제조방법 및 항부정맥제로서의 용도 | |
| DE69010917D1 (de) | Muscarin-rezeptor-antagonisten. | |
| ES477709A1 (es) | Procedimiento de preparacion de nuevos compuestos cis- y trans-1,5-benzotiacepinicos. | |
| DE69217148T2 (de) | Isoxazole derivate als lichtschutzmittel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed |